Effect of differing antecedent hypoglycemia on counterregulatory responses to exercise in type 1 diabetes

American Journal of Physiology - Endocrinology and Metabolism

Volumn 290, Issue 6, 2006, Pages

  Galassetti, Pietro ^c   Tate, Donna ^a   Neill, Ray A ^a   Richardson, Antoinette ^a   Leu, Szu Yun ^c   Davis, Stephen N ^a,b  

^a VANDERBILT UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b VETERANS AFFAIRS MEDICAL CENTER   (United States)

^c UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

Catecholamines; Dose response; Glucagon; Glucose clamp

Indexed keywords

CATECHOLAMINE; GLUCAGON; GLUCOSE; HEMOGLOBIN A1C; HYDROCORTISONE; INSULIN;

ADRENALIN BLOOD LEVEL; ADULT; ARTICLE; CARDIOVASCULAR PARAMETERS; CLINICAL ARTICLE; CONTROLLED STUDY; CYCLING; EXERCISE; FEMALE; GLUCAGON BLOOD LEVEL; GLUCONEOGENESIS; GLUCOSE BLOOD LEVEL; GLUCOSE CLAMP TECHNIQUE; HUMAN; HYDROCORTISONE BLOOD LEVEL; HYPOGLYCEMIA; INSULIN BLOOD LEVEL; INSULIN DEPENDENT DIABETES MELLITUS; LIPOLYSIS; MALE; NORADRENALIN BLOOD LEVEL; PRIORITY JOURNAL;

ADULT; BLOOD GLUCOSE; DIABETES MELLITUS, TYPE 1; EPINEPHRINE; EXERCISE; FATTY ACIDS, NONESTERIFIED; FEMALE; GLUCOSE CLAMP TECHNIQUE; HORMONES; HUMANS; HYPOGLYCEMIA; INSULIN; LACTIC ACID; MALE; TIME FACTORS;

EID: 33744911608     PISSN: 01931849     EISSN: 15221555     Source Type: Journal    
DOI: 10.1152/ajpendo.00244.2005     Document Type: Article

References (43)

1. Aguilar-Parada E, Eisentraut AM, and Unger RH. Pancreatic glucagon secretion in normal and diabetic subjects. Am J Med Sci 257: 415-419, 1969.
2. American Diabetes Association. Diabetes mellitus and exercise. Diabetes Care 21: S40-S44, 1998.
3. Amiel SA, Tamborlane WV, Simonson DC, and Sherwin RS. Defective glucose counterregulation after strict control of insulin-dependent diabetes mellitus. N Engl J Med 316: 1376-1383, 1987.
4. Arslanian SA, Nixon PA, Beck D, and Drash AL. Impact of physical fitness and glycemic control on in vivo insulin action in adolescents with IDDM. Diabetes 13: 9-15, 1990.
5. Beaver WL, Wasserman K, and Whipp BJ. A new method for detecting anaerobic threshold by gas exchange. J Appl Physiol 60: 2020-2027, 1986.
6. Bottini P, Boschetti E, Pampanelli S, Ciofetta M, Del Sindaco P, Scionti L, Brunetti P, and Bolli GB. Contribution of autonomic neuropathy to reduce plasma adrenaline responses to hypoglycemia in IDDM. Diabetes 46: 814-823, 1997.
7. Boyle P, Kempers S, O'Connor A, and Nagy R. Brain glucose uptake and unawareness of hypoglycemia in patients with insulin-dependent diabetes mellitus. N Engl J Med 333: 1720-1731, 1995.
8. Causon R, Caruthers M, and Rodnight R. Assay of plasma catecholamines by liquid chromatography with electrical detection. Annal Biochem 116: 223-226, 1982.
9. Cherrington AD, Lacy WW, and Chiasson JL. Effect of glucagon on glucose production during insulin deficiency in the dog. J Clin Invest 62: 664-667, 1978.
10. Clarke WL, Cox DJ, Gonder-Frederick LA, Julian D, Schlundt D, and Polonsky W. The relationship between nonroutine use of insulin, food, and exercise and the occurrence of hypoglycemia in adults with IDDM and varying degrees of hypoglcyemia awareness and metabolic control. Diabetes Educ 23: 55-58, 1997.
11. Davis MR, Mellman MJ, and Shamoon H. Further defects in counterregulatory responses induced by recurrent hypoglycemia in IDDM. Diabetes 41: 1335-1340, 1992.
12. Davis SN, Galassetti P, Wasserman DH, and Tate D. Effect of gender on neuroendocrine and metabolic counterregulatory responses to exercise in normal man. J Clin Endocrinol Metab 85: 224-230, 2000.
13. Davis SN, Galassetti P, Wasserman DH, and Tate D. Effects of antecedent hypoglycemia on subsequent counterregulatory responses to exercise. Diabetes 49: 73-81, 2000.
14. Davis SN, Mann S, Galassetti P, Neill RA, Tate D, Ertl AC, and Costa F. Effects of differing durations of antecedent hypoglycemia on counterregulatory responses to subsequent hypoglycemia in normal humans. Diabetes 49: 1897-1903, 2000.
15. Davis SN, Shavers C, and Costa F. Prevention of an increase in plasma cortisol during hypoglycemia preserves subsequent counterregulatory responses. J Clin Invest 100: 429-438, 1997.
16. Davis SN, Shavers C, Costa F, and Mosqueda-Garcia R. Role of cortisol in the pathogenesis of deficient counterregulation after antecedent hypoglycemia in normal man. J Clin Invest 98: 680-691, 1996.
17. Davis SN, Shavers C, Mosqueda-Garcia R, and Costa F. Effects of differing antecedent hypoglycemia on subsequent counterregulation in normal humans. Diabetes 46: 1328-1335, 1997.
18. DeFronzo RA, Tobin K, and Andres R. Glucose clamp technique: a method for quantifying insulin secretion and resistance. Am J Physiol Endocrinol Metab Gastrointest Physiol 237: E216-E223, 1979.
19. Devlin J and Ruderman NB. Handbook of Exercise and Diabetes. Alexandria, VA: American Diabetes Association, 1995.
20. Galassetti P, Tate D, Neill RA, Morrey S, and Wasserman DH. Effect of antecedent hypoglycemia on counterregulatory responses to subsequent euglycemic exercise in type 1 diabetes. Diabetes 52: 1761-1769, 2003.
21. Gerich JE, Langlois M, Noacco C, Karam J, and Forsham PH. Lack of a glucagon response to hypoglycemia in diabetes: evidence for an intrinsic pancreatic alpha-cell defect. Science 182: 171-173, 1973.
22. Hagopian W, Lever E, Cen D, Emmounoud D, Polonsky K, Pugh W, Moosa A, and Jaspan JB. Predominance of renal and absence of hepatic metabolism of pancreatic polypeptide in the dog. Am J Physiol Renal Fluid Electrolyte Physiol 245: F171-F177, 1983.
23. Heller SR and Cryer PE. Reduced neuroendocrine and symptomatic responses to subsequent hypoglycemia after one episode of hypoglycemia in nondiabetic humans. Diabetes 40: 223-226, 1991.
24. Ho RJ. Radiochemical assay of long chain fatty acid using 63NI as tracer. Anal Biochem 26: 105-113, 1970.
25. Hunter W and Greenwood F. Preparation of [131I]-labeled human growth hormone of high specific activity. Nature 194: 495-496, 1962.
26. Landt KW, Campaigne BN, James FW, and Sperling MA. Effects of exercise training on insulin sensitivity in adolescents with type 1 diabetes. Diabetes Care 8: 461-465, 1985.
27. Lloyd B, Burrin J, Smythe P, and Alberti KGMM. Enzymatic fluorometric continuous-flow assays for blood glucose lactate, pyruvate, alanine, glycerol, and 3-hydroxybutyrate. Clin Chem 24: 1724-1729, 1978.
28. Maran A, Cranston I, Lomas J, Macdonald I, and Amiel SA. Protection by lactate of cerebral function during hypoglycaemia. Lancet 343: 16-20, 1994.
29. Mosher PE, Nash S, Perry AC, LaPerriere AR, and Goldberg RB. Aerobic circuit exercise training: effect on adolescents with well-controlled insulin dependent diabetes mellitus. Arch Phys Med Rehabil 79: 652-657, 1998.
30. Rabasa-Lhoret R, Bourque J, Ducros F, and Chiasson JL. Guidelines for premeal insulin dose reduction for postprandial exercise of different intensities and durations in type 1 diabetic subjects treated intensively with a basal-bolus insulin regimen (ultralente-lispro). Diabetes Care 24: 625-630, 2001.
31. Sandoval D, Guy D, Richardson A, Ertl AC, and Davis SN. Effects of low and moderate antecedant exercise on counterregulatory responses to subsequent hypoglycemia in type 1 diabetes. Diabetes 53: 1798-1806, 2004.
32. Schneider S, Vitug A, Ananthakrishnan R, and Khachadurian A. Impaired adrenergic response to prolonged exercise in Type I diabetes. Metabolism 40: 1219-1225, 1991.
33. Sherwin RS, Kramer K, Robin J, and Andres R. A model of the kinetics of insulin in man. J Clin Invest 53: 1481-1492, 1978.
34. Sonnenberg GE, Kemmer FW, and Berger M. Exercise in type I (insulin-dependent) diabetic patients treated with continuous subcutaneous insulin infusion: prevention of exercise-induced hypoglycaemia. Diabetologia 33: 696-703, 1990.
35. Stratton R, Wilson DP, Endres RK, and Goldstein DE. Improved glycemic control after supervised 8-wk exercise program in insulindependent diabetic adolescents. Diabetes Care 10: 589-593, 1987.
36. Veneman T, Mitrakou A, Mokan M, Cryer PE, and Gerich JE. Effects of hyperketonemia or hyperlacticacidemia on symptoms, cognitive dysfunction, and counterregulatory hormone responses during hypoglycemia in normal humans. Diabetes 43: 1311-1317, 1994.
37. Wall JS, Steele R, DeBodo RD, and Altszuler N. Effect of insulin on utilization and production of circulating glucose. Am J Physiol 189: 43-50, 1957.
38. Wasserman K. The anaerobic threshold measurement to evaluate exercise performance. Am Rev Respir Dis 129: 535-540, 1984.
39. Wasserman K, Beaver WL, Davis JA, Pu JZ, and Whipp BJ. Lactate, pyruvate and lactate-to-pyruvate ratio during exercise and recovery. J Appl Physiol 59: 935-940, 1985.
40. Wide L and Porath J. Radioimmunoassay of proteins with the use of sephadex-coupled antibodies. Biochim Biophys Acta 130: 257-260, 1966.
41. Widom B and Simonson D. Intermittent hypoglycemia impairs glucose counterregulation. Diabetes 41: 1597-1602, 1992.
42. Wiesinger GF, Pleiner J, Quittan M, Fuchsjager-Mayrl G, Crevenna R, Nuhr MJ, Francesconi C, Fialka-Moser V, and Woltz M. Health related quality of life in patients with long-standing insulin-dependent (type 1) diabetes mellitus: benefits of regular physical training. Wien Klin Wochenschr 113: 670-675, 2001.
43. Yale JF, Begg I, Gerstein H, Houlden R, Jones H, Maheux P, and Pacaud D. 2001 Canadian Diabetes Association Clinical Practice Guidelines for the Prevention and Management of Hypoglycemia in Diabetes. Can J Diabet 26: 22-35, 2001.